CN116396925A - Proliferation method of hair follicle stem cells - Google Patents
Proliferation method of hair follicle stem cells Download PDFInfo
- Publication number
- CN116396925A CN116396925A CN202310508383.2A CN202310508383A CN116396925A CN 116396925 A CN116396925 A CN 116396925A CN 202310508383 A CN202310508383 A CN 202310508383A CN 116396925 A CN116396925 A CN 116396925A
- Authority
- CN
- China
- Prior art keywords
- hair follicle
- follicle stem
- stem cells
- serum
- culture medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003780 hair follicle Anatomy 0.000 title claims abstract description 115
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 115
- 230000035755 proliferation Effects 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 24
- 210000003491 skin Anatomy 0.000 claims abstract description 29
- 239000006285 cell suspension Substances 0.000 claims abstract description 26
- 239000004017 serum-free culture medium Substances 0.000 claims abstract description 26
- 210000004027 cell Anatomy 0.000 claims description 19
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 10
- 238000004140 cleaning Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 230000002062 proliferating effect Effects 0.000 claims description 9
- 239000012583 B-27 Supplement Substances 0.000 claims description 8
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 8
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 8
- 239000012580 N-2 Supplement Substances 0.000 claims description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 7
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 7
- 102000004877 Insulin Human genes 0.000 claims description 7
- 108090001061 Insulin Proteins 0.000 claims description 7
- 230000029087 digestion Effects 0.000 claims description 7
- AZHSSKPUVBVXLK-UHFFFAOYSA-N ethane-1,1-diol Chemical compound CC(O)O AZHSSKPUVBVXLK-UHFFFAOYSA-N 0.000 claims description 7
- 239000012091 fetal bovine serum Substances 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 7
- 229940125396 insulin Drugs 0.000 claims description 7
- 210000002615 epidermis Anatomy 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 108010019160 Pancreatin Proteins 0.000 claims description 5
- 230000001464 adherent effect Effects 0.000 claims description 5
- 210000004556 brain Anatomy 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 5
- 230000000249 desinfective effect Effects 0.000 claims description 5
- 229940055695 pancreatin Drugs 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 229920006395 saturated elastomer Polymers 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 210000001519 tissue Anatomy 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 230000003416 augmentation Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 238000004113 cell culture Methods 0.000 abstract description 3
- 239000012679 serum free medium Substances 0.000 abstract 1
- 230000024245 cell differentiation Effects 0.000 description 5
- 230000032823 cell division Effects 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 210000004504 adult stem cell Anatomy 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000000487 effect on differentiation Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 108010077544 Chromatin Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000000110 microvilli Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0627—Hair cells
- C12N5/0628—Hair stem cells; Hair progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/35—Polyols, e.g. glycerin, inositol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C12N2509/10—Mechanical dissociation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention provides a proliferation method of hair follicle stem cells, relates to the technical field of hair follicle stem cell culture, and aims to solve the problems of less stock of hair follicle stem cells and higher acquisition difficulty; preparing a serum-free medium; adding serum-free culture medium into hair follicle stem cell suspension, and performing primary culture to obtain primary hair follicle stem cells; inoculating the primary hair follicle stem cells into a culture flask, and adding a serum-free culture medium for proliferation culture; the obtained skin sample is used for obtaining the hair follicle stem cells, so that the hair follicle stem cells with activity can be ensured to be obtained, and the subsequent proliferation culture of the hair follicle stem cells is facilitated; the stem cells are collected, isolated, cultured and amplified, and the like, so that the hair follicle primordium is proliferated, the preparation of the hair follicle stem cells is achieved, the difficulty in obtaining the hair follicle stem cells is reduced, and the stock is increased.
Description
Technical Field
The invention relates to the technical field of hair follicle stem cell culture, in particular to a proliferation method of hair follicle stem cells.
Background
Hair follicle stem cells are one of the perifollicular sheath bulge in humans. Hair follicle stem cells belong to adult stem cells, are in a static state in vivo, and show a remarkable proliferation capacity under the in vitro culture effect. It has been found that hair follicle stem cells have a multipotent differentiation potential, which can differentiate into epidermis, hair follicle, sebaceous glands, involved in the process of wound healing in the skin.
The hair follicle stem cells are in hair follicles, and have the characteristics of slow periodicity, undifferentiated property, strong self-renewal capacity, strong in vitro proliferation capacity and the like as other adult stem cells. Hair follicle stem cells differentiate through three stages of mitotically post-differentiated cells of the hair follicle stem cells, transient proliferating cells. Hair follicle stem cells are cubic under a microscope, have small cell volume, large nuclear plasma ratio, smooth surface and less wrinkles, are also called as non-zigzag cells, and the increase of the cell volume is inversely related to the proliferation capacity. Ultrastructural display a few microvilli on the cell surface, many curls on the nucleus, and a diffuse distribution of chromatin, all of which are characteristic of the original cell.
One of the most important features of hair follicle stem cells is the slow periodicity, and can have an infinite number of cell cycles. When exposed to nucleotides with other labels of the nuclide, the cells take up the labeled nucleotides during DNA synthesis and integrate the label into the DNA. Such markers can be maintained for a considerable period of time due to the long cell cycle of stem cells. It is due to this characteristic of stem cells that it is known as labelling resident cells.
Cell proliferation is an important vital feature of organisms, cells proliferate in a dividing manner. Single cell organisms produce new individuals in a cell division manner. Multicellular organisms produce new cells in a cell division manner to supplement senescent or dead cells in the body.
Multicellular organisms can be developed from a fertilized egg, through cell division and differentiation, to ultimately produce a new multicellular individual. It must be emphasized that by cell division, the replicated genetic material can be equally distributed into the two daughter cells. It can be seen that cell proliferation is the basis for the growth, development, proliferation and inheritance of organisms.
At present, the stock of hair follicle stem cells is less, the acquisition difficulty is high, the culture quality is required to be improved, and the hair follicle stem cells need to be further cultured so as to meet the actual application requirements; therefore, there is a need for a method of proliferating hair follicle stem cells to solve the above problems.
Disclosure of Invention
In view of the problems existing in the prior art, the invention discloses a proliferation method of hair follicle stem cells, which adopts the technical scheme that the proliferation method comprises the following steps:
step 1, extracting hair follicle stem cells from human back brain epidermis in a sterile room to obtain hair follicle stem cell suspension;
step 2, preparing a serum-free culture medium;
step 3, adding a serum-free culture medium into the hair follicle stem cell suspension, and performing primary culture to obtain primary hair follicle stem cells;
and step 4, inoculating the primary hair follicle stem cells into a culture bottle, adding a serum-free culture medium for proliferation culture, and obtaining the hair follicle stem cells by using the obtained skin sample, so that the hair follicle stem cells with activity can be ensured to be obtained, and the subsequent proliferation culture of the hair follicle stem cells is facilitated.
In a preferred embodiment of the present invention, in the step 1, the step of extracting hair follicle stem cells to obtain a hair follicle stem cell suspension further comprises the steps of:
step a, after cleaning dirt on the surface of a skin sample, disinfecting and cleaning the skin sample;
step b, cutting the skin sample into blocks, adding PBS for digestion treatment until the tissue blocks become soft;
and c, centrifuging the digested mixture, and taking out supernatant to obtain hair follicle stem cell suspension.
In the step a, the skin sample is sterilized with 75% alcohol and then washed with concentrated salt buffer solution, and the surface of the skin sample is cleaned and sterilized to avoid the influence of other bacteria or dirt in the skin sample on the acquisition of hair follicle stem cells.
In the step b, PBS containing pancreatin and bilirubin is adopted and put into a constant-temperature water bath at 37 ℃ to digest for 1-2 hours, and links such as stem cell collection, separation culture, culture expansion and the like are carried out to proliferate hair follicle primordium, so that the preparation of hair follicle stem cells is achieved, the acquisition difficulty of the hair follicle stem cells is reduced, and the stock is increased.
As a preferable technical scheme of the invention, in the step c, the mixture is centrifugally separated at 800-1200r/min in the centrifugal treatment.
As a preferred technical scheme of the invention, in the step 2, the serum-free culture medium comprises 35-45mL of DMEM culture medium, 1-10 mug/mL of insulin, 1-100ng/mL of EGF, 1-100ng/mL of FGF-2, 0.1-0.4 mug/mL of B27 supplement, 20-40ng/mL of N2 supplement, 25-50 mug of hydroxyl ethanol and 14-16% of fetal bovine serum by volume percentage.
As a preferred technical scheme of the invention, the serum-free culture medium comprises 38mL of DMEM culture medium, 4 mu g/mL of insulin, 40ng/mL of EGF, 60ng/mL of FGF-2, 0.2 mu g/mL of B27 supplement, 28ng/mL of N2 supplement, 33 mu L of hydroxyl ethanol and 15% by volume of fetal bovine serum.
B27 supplement: is a serum-free culture medium additive, and contains various nutrients such as vitamins, amino acids, lipids, etc. required for cell growth and differentiation.
N2 supplement: is a serum-free culture medium additive, and contains various nutrients such as vitamins, amino acids, lipids, etc. required for cell growth and differentiation.
FGF-2: is a growth factor, can promote cell proliferation and differentiation, and has promoting effect on growth and differentiation of hair follicle stem cells.
EGF: is a growth factor, can promote cell proliferation and differentiation, and has promoting effect on growth and differentiation of hair follicle stem cells.
As a preferred embodiment of the present invention, in the step 3, the hair follicle stem cell suspension is placed in 5% CO at 37 ℃ 2 Culturing in saturated humidity environment for 4-8 hr, and half-changing liquid to eliminate non-adherent cells; when half liquid exchange is repeatedly carried out for 2-3 times, the high-purity primary hair follicle stem cells are obtained, the proliferation method recorded in the technical scheme is simple and convenient in operation link and controllable in preparation cost, the hair follicle stem cells are high in culture quality, the demand satisfaction degree is improved, and the popularization value is correspondingly improved.
The invention has the beneficial effects that: the hair follicle stem cells are obtained by utilizing the obtained skin sample, so that the hair follicle stem cells with activity can be ensured to be obtained, and the subsequent proliferation culture of the hair follicle stem cells is facilitated; the surface of the skin sample is cleaned and disinfected, so that the influence of other miscellaneous bacteria or dirt in the skin sample on the acquisition of hair follicle stem cells is avoided; the stem cells are collected, isolated, cultured and amplified, and the like, so that the hair follicle primordium is proliferated, the preparation of the hair follicle stem cells is achieved, the difficulty in obtaining the hair follicle stem cells is reduced, and the stock is increased.
Furthermore, the proliferation method recorded in the technical scheme is simple and convenient in operation link, controllable in preparation cost, high in hair follicle stem cell culture quality, high in demand satisfaction and high in popularization value.
Detailed Description
Example 1
The invention discloses a proliferation method of hair follicle stem cells, which adopts the technical scheme that the proliferation method comprises the following steps:
step 1, extracting hair follicle stem cells from human back brain epidermis in a sterile room to obtain hair follicle stem cell suspension;
extracting hair follicle stem cells, and obtaining hair follicle stem cell suspension further comprises the following steps:
step a, after cleaning dirt on the surface of a skin sample, disinfecting and cleaning the skin sample;
in the step a, the skin sample is sterilized by 75% alcohol and then is washed by concentrated salt buffer solution;
step b, cutting the skin sample into blocks, adding PBS for digestion treatment until the tissue blocks become soft;
in the step b, PBS containing pancreatin and bilirubin is adopted, and the mixture is put into a constant-temperature water bath with the temperature of 37 ℃ for digestion for 1 hour;
step c, centrifuging the digested mixture, and taking out supernatant to obtain hair follicle stem cell suspension;
in the step c, the mixture is centrifugally separated at 800r/min in the centrifugal treatment;
the obtained skin sample can be used for obtaining the hair follicle stem cells, so that the hair follicle stem cells with activity can be obtained, and the subsequent proliferation culture of the hair follicle stem cells is facilitated.
Step 2, preparing a serum-free culture medium;
in the step 2, the serum-free culture medium comprises 35mL of DMEM culture medium, 1 mu g/mL of insulin, 1ng/mL of EGF, 1ng/mL of FGF-2, 0.1 mu g/mL of B27 supplement, 20ng/mL of N2 supplement, 25 mu L of hydroxy ethanol and 14% by volume of fetal bovine serum;
step 3, adding a serum-free culture medium into the hair follicle stem cell suspension, and performing primary culture to obtain primary hair follicle stem cells;
placing hair follicle stem cell suspension into 5% CO at 37deg.C 2 Culturing for 4 hours in a saturated humidity environment, and performing half liquid exchange to remove non-adherent cells; when half liquid exchange is repeatedly carried out for 2 times, the primary hair follicle stem cells with high purity are obtained;
and 4, inoculating the primary hair follicle stem cells into a culture flask, and adding a serum-free culture medium for proliferation culture.
Example 2
The invention discloses a proliferation method of hair follicle stem cells, which adopts the technical scheme that the proliferation method comprises the following steps:
step 1, extracting hair follicle stem cells from human back brain epidermis in a sterile room to obtain hair follicle stem cell suspension;
extracting hair follicle stem cells, and obtaining hair follicle stem cell suspension further comprises the following steps:
step a, after cleaning dirt on the surface of a skin sample, disinfecting and cleaning the skin sample;
in the step a, the skin sample is sterilized by 75% alcohol and then is washed by concentrated salt buffer solution;
step b, cutting the skin sample into blocks, adding PBS for digestion treatment until the tissue blocks become soft;
in the step b, PBS containing pancreatin and bilirubin is adopted, and the mixture is put into a constant-temperature water bath with the temperature of 37 ℃ for digestion for 2 hours;
step c, centrifuging the digested mixture, and taking out supernatant to obtain hair follicle stem cell suspension;
in the step c, the mixture is centrifugally separated at 1200r/min in the centrifugal treatment;
step 2, preparing a serum-free culture medium;
in the step 2, the serum-free culture medium comprises 45mL of DMEM culture medium, 10 mu g/mL of insulin, 100ng/mL of EGF, 100ng/mL of FGF-2, 0.4 mu g/mL of B27 supplement, 40ng/mL of N2 supplement, 50 mu L of hydroxyl ethanol and 16% by volume of fetal bovine serum;
step 3, adding a serum-free culture medium into the hair follicle stem cell suspension, and performing primary culture to obtain primary hair follicle stem cells;
placing hair follicle stem cell suspension into 5% CO at 37deg.C 2 Culturing for 8 hours in a saturated humidity environment, and performing half liquid exchange to remove non-adherent cells; when half liquid exchange is repeatedly carried out for 2 times, the primary hair follicle stem cells with high purity are obtained;
and 4, inoculating the primary hair follicle stem cells into a culture flask, and adding a serum-free culture medium for proliferation culture.
Example 3
The invention discloses a proliferation method of hair follicle stem cells, which adopts the technical scheme that the proliferation method comprises the following steps:
step 1, extracting hair follicle stem cells from human back brain epidermis in a sterile room to obtain hair follicle stem cell suspension;
extracting hair follicle stem cells, and obtaining hair follicle stem cell suspension further comprises the following steps:
step a, after cleaning dirt on the surface of a skin sample, disinfecting and cleaning the skin sample;
in the step a, the skin sample is sterilized by 75% alcohol and then is washed by concentrated salt buffer solution;
step b, cutting the skin sample into blocks, adding PBS for digestion treatment until the tissue blocks become soft;
in the step b, PBS containing pancreatin and bilirubin is adopted, and the mixture is put into a constant-temperature water bath with the temperature of 37 ℃ to be digested for 1.5 hours;
step c, centrifuging the digested mixture, and taking out supernatant to obtain hair follicle stem cell suspension;
in the step c, the mixture is centrifugally separated at 1000r/min in the centrifugal treatment;
step 2, preparing a serum-free culture medium;
in the step 2, the serum-free culture medium comprises 40mL of DMEM culture medium, 5.5 mu g/mL of insulin, 50ng/mL of EGF, 50ng/mL of FGF-2, 0.25 mu g/mL of B27 supplement, 30ng/mL of N2 supplement, 37 mu L of hydroxyl ethanol and 15% by volume of fetal bovine serum;
step 3, adding a serum-free culture medium into the hair follicle stem cell suspension, and performing primary culture to obtain primary hair follicle stem cells;
placing hair follicle stem cell suspension into 5% CO at 37deg.C 2 Culturing for 6 hours in a saturated humidity environment, and performing half liquid exchange to remove non-adherent cells; when half liquid exchange is repeatedly carried out for 3 times, the primary hair follicle stem cells with high purity are obtained, and the hair follicle primordium is proliferated by carrying out links such as stem cell collection, separation culture, culture amplification and the like, so that the preparation of the hair follicle stem cells is achieved, the obtaining difficulty of the hair follicle stem cells is reduced, and the stock is increased;
and 4, inoculating the primary hair follicle stem cells into a culture flask, and adding a serum-free culture medium for proliferation culture.
Although the specific embodiments of the present invention have been described in detail, the present invention is not limited to the above embodiments, and various changes and modifications without inventive labor may be made within the scope of the present invention without departing from the spirit of the present invention, which is within the scope of the present invention.
Claims (8)
1. A method of proliferating hair follicle stem cells, comprising the steps of:
step 1, extracting hair follicle stem cells from human back brain epidermis in a sterile room to obtain hair follicle stem cell suspension;
step 2, preparing a serum-free culture medium;
step 3, adding a serum-free culture medium into the hair follicle stem cell suspension, and performing primary culture to obtain primary hair follicle stem cells;
and 4, inoculating the primary hair follicle stem cells into a culture flask, and adding a serum-free culture medium for proliferation culture.
2. The method for proliferating hair follicle stem cells according to claim 1, wherein: in the step 1, the hair follicle stem cells are extracted, and the hair follicle stem cell suspension is obtained further comprising the following steps:
step a, after cleaning dirt on the surface of a skin sample, disinfecting and cleaning the skin sample;
step b, cutting the skin sample into blocks, adding PBS for digestion treatment until the tissue blocks become soft;
and c, centrifuging the digested mixture, and taking out supernatant to obtain hair follicle stem cell suspension.
3. The method for proliferating hair follicle stem cells according to claim 2, wherein: in the step a, the skin sample is sterilized by 75% alcohol and then washed by a concentrated salt buffer solution.
4. The method for proliferating hair follicle stem cells according to claim 2, wherein: in the step b, PBS containing pancreatin and bilirubin is adopted, and the mixture is put into a constant temperature water bath with the temperature of 37 ℃ to be digested for 1-2 hours.
5. The method for proliferating hair follicle stem cells according to claim 2, wherein: in the step c, the mixture is centrifugally separated at 800-1200 r/min.
6. The method for proliferating hair follicle stem cells according to claim 1, wherein: in the step 2, the serum-free culture medium comprises 35-45mL of DMEM culture medium, 1-10 mu g/mL of insulin, 1-100ng/mL of EGF, 1-100ng/mL of FGF-2, 0.1-0.4 mu g/mL of B27 supplement, 20-40ng/mL of N2 supplement, 25-50 mu L of hydroxyl ethanol and 14-16% of fetal bovine serum by volume percentage.
7. The method for proliferating hair follicle stem cells according to claim 6, wherein: the serum-free culture medium comprises 38mL of DMEM culture medium, 4 mu g/mL of insulin, 40ng/mL of EGF, 60ng/mL of FGF-2, 0.2 mu g/mL of B27 supplement, 28ng/mL of N2 supplement, 33 mu L of hydroxyl ethanol and 15% by volume of fetal bovine serum.
8. An augmentation of hair follicle stem cells according to claim 1A method of reproduction characterized by: in the step 3, the hair follicle stem cell suspension is put into 5% CO at 37 DEG C 2 Culturing in saturated humidity environment for 4-8 hr, and half-changing liquid to eliminate non-adherent cells; and (3) after half liquid exchange is repeatedly carried out for 2-3 times, obtaining the primary hair follicle stem cells with high purity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310508383.2A CN116396925A (en) | 2023-05-08 | 2023-05-08 | Proliferation method of hair follicle stem cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310508383.2A CN116396925A (en) | 2023-05-08 | 2023-05-08 | Proliferation method of hair follicle stem cells |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116396925A true CN116396925A (en) | 2023-07-07 |
Family
ID=87010615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310508383.2A Pending CN116396925A (en) | 2023-05-08 | 2023-05-08 | Proliferation method of hair follicle stem cells |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116396925A (en) |
-
2023
- 2023-05-08 CN CN202310508383.2A patent/CN116396925A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101203601B (en) | Transplantation of differentiated immature adipocytes and biodegradable scaffold for tissue augmentation | |
EP2368974A1 (en) | Methods for isolating mesenchymal stem cells from embryos of human or animals and extracting secretion substances thereof | |
CN104263699A (en) | Culture method for large-scale preparation of clinical treatment level dermal multipotent stem cells for cell transplantation | |
CN110974944B (en) | Mesenchymal stem cell composite active factor freeze-dried powder and preparation method and application thereof | |
CN104312970A (en) | Preparation method of clinical treatment level epidermal stem cell for cell therapy by applying human extracellular matrix screening and mass culture | |
CN101914495A (en) | Culture method for largely amplifying hair follicle stem cells in vitro | |
CN113564111B (en) | Method for culturing umbilical cord-derived mesenchymal stem cells in low-oxygen mode | |
CN105255822A (en) | Method for screening and culturing extracellular hair follicle stem cell matrix for clinic treatment level cell therapy | |
CN111956668B (en) | Skin regeneration and repair cell composition and preparation method thereof | |
US11840706B2 (en) | Composition and method for generating a desired cell type and/or tissue type from hair follicular stem cells | |
CN113502259A (en) | Isolated culture method of hair follicle stem cells | |
Benda et al. | Urine as a source of stem cells | |
CN104263698A (en) | Screening and culturing methods for large-scale preparation of human extracellular matrix from fibroblasts for clinical treatment level cellular therapy | |
CN102021143B (en) | Pretreatment method for improving migration capability of mesenchymal stem cells | |
CN105238739A (en) | Selective culture method for large-scale preparation of human extracellular matrix through melanocytes for clinic treatment level cell therapy | |
CN115627256B (en) | Multi-layer tissue engineering skin composed of hair follicle cells and preparation method and application thereof | |
CN116396925A (en) | Proliferation method of hair follicle stem cells | |
CN105238740A (en) | In-vitro screening and culturing method for tissue engineering skin seed epidermal keratinocyte high-simulation in-vivo cell extracellular matrix attachment | |
CN112608947B (en) | Construction method and application of immortalized human sebaceous gland cell line | |
CN104726407A (en) | Method for increasing yield of neural stem cells in adult nerve tissues by utilizing organotypic culture | |
CN114276986A (en) | Method for separating and purifying buffalo primary myoblasts and application thereof | |
EP3766963A1 (en) | Method of culturing mesenchymal stem cells | |
CN112773759A (en) | Preparation method of paracrine factor inclusion body with skin cell rejuvenation effect | |
RU2272638C1 (en) | Biotransplant, method for its preparing and method for treatment of chronic hepatitis and liver cirrhosis (variants) | |
CN111939176B (en) | Skin injury repairing agent containing adipose-derived stem cells and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |